IQQG:XETRA:XETRA-iShares EURO Total Market Growth Large UCITS (EUR)

ETF | Others |

Last Closing

USD 59.98

Change

-0.78 (-1.28)%

Market Cap

USD 0.29B

Volume

153.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B

ETFs Containing IQQG:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.62% 55% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.62% 54% F 56% F
Trailing 12 Months  
Capital Gain 24.03% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.03% 73% C 72% C
Trailing 5 Years  
Capital Gain 59.03% 73% C 73% C
Dividend Return 2.01% 24% F 11% F
Total Return 61.04% 74% C 72% C
Average Annual (5 Year Horizon)  
Capital Gain 11.10% N/A N/A 72% C
Dividend Return 11.50% N/A N/A 72% C
Total Return 0.40% N/A N/A 21% F
Risk Return Profile  
Volatility (Standard Deviation) 16.23% N/A N/A 42% F
Risk Adjusted Return 70.89% N/A N/A 74% C
Market Capitalization 0.29B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike